(Hypertension. 2000;36:78.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
From the Departments of Neurosurgery (D.G., S.J.P.), Radiology (J.C., P.VT.), Medicine (B.E.), and Biometry (P.R), Medical University of South Carolina, Charleston.
Correspondence to Sunil J. Patel, MD, Neurosurgery, CSB 428, 96 Jonathan Lucas St, Charleston, SC 29425. E-mail patels{at}musc.edu
| Abstract |
|---|
|
|
|---|
Key Words: hypertension, essential norepinephrine medulla oblongata clonidine sympathetic nervous system
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
At the initial visit (during which the patients history was obtained
and the physical examination was performed), blood pressure and heart
rate were measured in triplicate with a standard mercury
sphygmomanometer and an appropriately sized arm cuff after the patient
had rested for 5 minutes in a seated position. All antihypertensive
medications were then discontinued. Blood pressure was recorded
with the patient seated every day by each patient and by a nurse on 2
separate occasions
1 week apart for the next 2 weeks. Subjects with
mean systolic and/or diastolic blood pressure
readings in the range of 140 to 179/90 to 109 mm Hg were enrolled
in the study and proceeded to the protocol described below.
Clonidine Suppression Test
Subjects reported to the General Clinical Research Center in the
morning after an overnight fast beginning at 10:00 PM. Each
subject was asked to lie comfortably supine on a bed during the entire
period of testing. An intravenous catheter was placed and
was flushed periodically with heparinized saline to maintain patency.
One hour later, baseline blood pressure was recorded in triplicate
by means of a random-zero sphygmomanometer. Heart rate was measured,
and an electrocardiogram was performed. Blood was drawn
for use in determining baseline plasma norepinephrine
concentration. After the baseline measurements had been completed,
clonidine (0.3 mg) was administered orally. Blood pressure and heart
rate were recorded hourly for the next 3 hours. The heparinized
cannula was then removed, an appointment for a posterior fossa MRI was
provided, and the subject was discharged from the General Clinical
Research Center. Supine and standing blood pressure and pulse rate were
recorded before each subject was discharged. None of the subjects
experienced orthostatic hypotension caused by
clonidine.
MRI Scan
Magnified high-resolution T1-weighted 3D spoiled GRASS images were
obtained to provide precise anatomic details of the relationship
between the surface of the medulla and any vessels in the surrounding
cisterns. A record was made of the name and location (left or
right) of each vessel and its position (touching [T] or not touching
[NT]) with respect to the medullary surface. The specific area of
interest was the ROS just anterior to the root entry zone of the
glossopharyngeal and vagus nerves. Two neuroradiologists (J.C. and
P.V.) independently reported their findings with regard to each
subjects MRI scan. After 3 months, each neuroradiologist was asked to
reread the MRI scans in random order. They were unaware of the previous
readings and were not informed of the clonidine suppression test
results. In addition, another author (S.J.P.), who was also unaware of
clonidine suppression test results, independently reviewed the MRI
scans.
Biochemical Measurements
Plasma norepinephrine was measured by
high-performance liquid
chromatography separation and electrochemical
detection. The sensitivity of the assay was 5 pg/mL.
Data Analysis
The most important analysis was that of the presence or
absence of vascular contact with the ROS as possibly correlating with
the baseline plasma norepinephrine concentration. The age,
gender, race, mean blood pressure, and depressor response to clonidine
were evaluated as the modifiers of such a relationship. Multiple
regressions were therefore planned, with plasma
norepinephrine as the dependent variable. The same
technique was also applied with clonidine depressor response as the
dependent variable.
| Results |
|---|
|
|
|---|
|
|
|
|
The clonidine depressor response tended to be greater in the 5 subjects with vascular contact (-20.6±3.2 mm Hg) compared with that observed in the 13 subjects without contact (-13.6±9.3 mm Hg). However, the difference between the 2 groups was not statistically significant. The overall depressor response (-15.6 mm Hg) was significantly affected by baseline mean blood pressure (P=0.0003) and race (P=0.0021). The estimation regression is depressor response=13.755 to 0.431x(blood pressure+8.674)xrace, where for the latter, 1 denotes "white" and 2 denotes "black," with the conditional standard error=4.8 mm Hg.
| Discussion |
|---|
|
|
|---|
Only 27.5% of the subjects with hypertension were found to have vascular contact of the ROS in this study. This is much lower than the previously reported incidence of vascular compression along the VLM and may be a result of the stricter anatomic criteria of vascular contact that occurs only in the ROS. Another reason may be that only those in whom all 3 investigators reported vascular contact were considered to have it, which would eliminate any doubt about this finding. Finally, the small number of subjects in this study may account for some of the variation.
Arterial pulsatile compression may either directly stimulate the C1 neurons of the RVLM or disinhibit them via an effect on the caudal ventrolateral medulla, which results in elevation of central sympathetic outflow or tone. In such a group of hypertensives, sympathetic tone should show a positive association with vascular compression of the ROS. In fact, all 5 subjects with vascular contact along the left ROS, which is the presumed location of the C1 neurons, exhibited clinical evidence of neurogenic hypertension. The 5 "affected" patients had higher baseline plasma norepinephrine concentrations than those of the 13 subjects without vascular contact along the left ROS. In this study, the clonidine depressor response (sympathetic dependence of blood pressure) was higher in the group that exhibited vascular contact. A larger number of subjects may prove this to be a significant finding.
We have demonstrated in this small group of hypertensive patients that those with vascular compression of the left ROS had elevated plasma norepinephrine concentrations. These findings are consistent with the hypothesis that vascular contact of the left ROS is etiologically related to neurogenic hypertension. The use of clinical criteria for neurogenic hypertension and improved MRI techniques may help to define such a specific group of patients who may benefit consistently from microvascular decompression.
The small number of subjects studied precludes us from making definitive statements about the specific cause of hypertension in these patients. Also, decubital blood represents a pooled sample with regard to the catecholamine level and may not accurately reflect the central sympathetic tone. However, the results provide a basis with which future studies could examine the relationship between MRI findings and more sensitive measures of central sympathetic outflow, such as microneurography, in a larger number of patients. These studies may help to substantiate our hypothesis of the pathogenesis of elevated blood pressure in patients with neurogenic "essential" hypertension.
| Acknowledgments |
|---|
Received October 1, 1999; first decision November 29, 1999; accepted February 3, 2000.
| References |
|---|
|
|
|---|
2. Ross CA, Ruggiero DA, Park DH, Tong HJ, Sved AF, Fernandez-Pardal J, Saavedra JM, Reis DJ. Tonic vasomotor control by the rostral ventrolateral medulla: effect of electrical or chemical stimulation of the area containing C1 adrenaline neurons on arterial pressure, heart rate and plasma catecholamines and vasopressin. J Neurosci. 1984;4:474494.[Abstract]
3. Dormer KJ, Bedford TG. Cardiovascular control by the rostral ventrolateral medulla in the conscious dog. Prog Brain Res. 1989;81:265277.
4. Jannetta PJ, Segal R, Wolfson SK Jr, Dujovny M, Semba A, Cook EE. Neurogenic hypertension: etiology and surgical treatment, II: observation in an experimental non-human primate model. Ann Surg.. 1985;202:253261.[Medline] [Order article via Infotrieve]
5. Tork I. Anatomy of the serotonergic system. Ann N Y Acad Sci.. 1990;600:935.[Medline] [Order article via Infotrieve]
6. Reis DJ, Golanvo EV. Autonomic and vasomotor regulation. Int Rev Neurobiol.. 1997;41:121149.[Medline] [Order article via Infotrieve]
7. Aicher SA, Saravay RH, Carvo S, Jeske I, Morrison SF, Reis DJ, Milner TA. Monosynaptic projection from the nucleus tractus solitarii to C1 adrenergic neurons in the rostral ventrolateral medulla: comparison with input from the caudal ventrolateral medulla. J Comp Neurol.. 1996;373:6275.[Medline] [Order article via Infotrieve]
8. Halliday GM, Li YW, Joh TH, Cotton RG, Howe PR, Geffen LB, Blessing WW. Distribution of monoamine synthesizing neurons in the human medulla oblongata. J Comp Neurol. 1988;273:301317.[Medline] [Order article via Infotrieve]
9. Akimura T, Furautani Y, Jimi Y, Saito K, Kashiwagi S, Kato S, Ito H. Essential hypertension and neurovascular compression at the ventrolateral medulla oblongata: MR evaluation. AJNR Am J Neuroradiol.. 1995;16:401405.[Abstract]
10. Naraghi R, Gaab MR, Walter GF, Klienberg B. Arterial hypertension and neurovascular compression at the ventrolateral medulla. J Neurosurg.. 1992;77:103112.[Medline] [Order article via Infotrieve]
11. Naraghi R, Geiger H, Crnac J, Huk W, Fahlbusch R, Engels G, Luft FC. Posterior fossa neurovascular anomalies in essential hypertension. Lancet.. 1994;344:14661470.[Medline] [Order article via Infotrieve]
12. Jannetta PJ, Segal R, Wolfson SK Jr. Neurogenic hypertension: etiology and surgical treatment, I: observation in 53 patients. Ann Surg.. 1985;201:391398.[Medline] [Order article via Infotrieve]
13. Fein JM, Frishman W. Neurogenic hypertension related to vascular compression of the lateral medulla. Neurosurgery.. 1980;6:615622.[Medline] [Order article via Infotrieve]
14. Levy EI, Clyde B, McLaughlin MR, Jannetta PJ. Microvascular decompression of the left lateral medulla oblongata for severe refractory neurogenic hypertension. Neurosurgery.. 1998;43:16.[Medline] [Order article via Infotrieve]
15. Geiger H, Naraghi R, Schobel HP, Frank H, Sterzel RB, Fahlbusch R. Decrease of blood pressure by ventrolateral medullary decompression in essential hypertension. Lancet.. 1998;352:446449.[Medline] [Order article via Infotrieve]
16. Goldstein DS, Levinson PD, Zimlichman R, Pitterman A, Stull R, Keiser HR. Clonidine suppression testing in essential hypertension. Ann Intern Med.. 1985;102:4248.
This article has been cited by other articles:
![]() |
J. S. Nicholas, S. J. D'Agostino, and S. J. Patel Arterial Compression of the Retro-Olivary Sulcus of the Ventrolateral Medulla in Essential Hypertension and Diabetes Hypertension, October 1, 2005; 46(4): 982 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Smith, J. F. M. Meaney, L. N. Graham, J. B. Stoker, A. F. Mackintosh, D. A. S. G. Mary, and S. G. Ball Relationship of neurovascular compression to central sympathetic discharge and essential hypertension J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1453 - 1458. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zizka, J. Ceral, P. Elias, J. Tintera, L. Klzo, M. Solar, and L. Straka Vascular Compression of Rostral Medulla Oblongata: Prospective MR Imaging Study in Hypertensive and Normotensive Subjects Radiology, January 1, 2004; 230(1): 65 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Schobel, H. Frank, R. Naraghi, H. Geiger, E. Titz, and K. Heusser Hypertension in Patients with Neurovascular Compression Is Associated with Increased Central Sympathetic Outflow J. Am. Soc. Nephrol., January 1, 2002; 13(1): 35 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Frank, H.P. Schobel, K. Heusser, H. Geiger, R. Fahlbusch, R. Naraghi, and N. M. Kaplan Long-Term Results After Microvascular Decompression in Essential Hypertension Editorial Comment Stroke, December 1, 2001; 32(12): 2950 - 2955. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |